Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-16 4:34 pm Purchase | 2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN | BIOTECHNOLOGY VALUE FUND L P | 2,777,245 9.990% | 2,777,245![]() (New Position) | Filing History |
| 2023-10-16 4:01 pm Purchase | 2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN | Citadel Advisors LLC | 1,593,936 5.700% | 1,593,936![]() (New Position) | Filing History |
| 2023-10-12 4:04 pm Purchase | 2023-10-02 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,792,927 9.990% | 2,792,927![]() (New Position) | Filing History |
| 2023-10-06 4:05 pm Purchase | 2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN | Commodore Capital LP | 2,367,884 9.900% | 792,884![]() (+50.34%) | Filing History |
| 2023-10-05 4:47 pm Purchase | 2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN | Point72 Asset Management, L.P. | 1,565,829 5.600% | 1,565,829![]() (New Position) | Filing History |
| 2023-08-09 4:15 pm Purchase | 2023-08-07 | 13G | VistaGen Therapeutics, Inc. VTGN | Commodore Capital LP | 1,575,000 19.700% | 1,575,000![]() (New Position) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | VistaGen Therapeutics, Inc. VTGN | BlackRock Inc. BLK | 0 0.000% | -408,932![]() (Position Closed) | Filing History |
| 2023-02-14 5:20 pm Sale | 2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ORBIMED ADVISORS LLC | 0 0.000% | -350,641![]() (Position Closed) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Commodore Capital LP | 0 0.000% | -348,530![]() (Position Closed) | Filing History |
| 2023-02-14 3:32 pm Sale | 2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -391,209![]() (Position Closed) | Filing History |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | BlackRock Inc. BLK | 408,932 5.900% | 12,459![]() (+3.14%) | Filing History |
| 2023-02-01 1:49 pm Sale | 2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | FRANKLIN RESOURCES INC BEN | 0 0.000% | -337,267![]() (Position Closed) | Filing History |
| 2022-08-12 5:15 pm Sale | 2022-07-22 | 13D | VistaGen Therapeutics, Inc. VTGN | Growth Equity Opportunities 17, LLC | 0 0.000% | -543,420![]() (Position Closed) | Filing History |
| 2022-07-08 4:05 pm Purchase | 2022-04-06 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II, L.P. | 689,910 10.000% | 155,000![]() (+28.98%) | Filing History |
| 2022-04-14 4:42 pm Purchase | 2022-04-04 | 13G | VistaGen Therapeutics, Inc. VTGN | Commodore Capital LP | 348,530 5.100% | 348,530![]() (New Position) | Filing History |
| 2022-02-15 2:51 pm Sale | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 391,209 5.900% | -24,290![]() (-5.85%) | Filing History |
| 2022-02-14 4:20 pm Purchase | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II, L.P. | 534,910 8.000% | 60,235![]() (+12.69%) | Filing History |
| 2022-02-11 4:58 pm Purchase | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ORBIMED ADVISORS LLC | 350,641 5.300% | 24,681![]() (+7.57%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | BlackRock Inc. BLK | 396,473 6.000% | 396,473![]() (New Position) | Filing History |
| 2022-02-04 10:54 am Purchase | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | FRANKLIN RESOURCES INC BEN | 337,267 5.100% | 337,267![]() (New Position) | Filing History |

